polycythaemia cures
TV SHOWS
Watch TV Shows
 
 
VIDEO TESTIMONY
Watch Patient Videos
Watch Patient Videos
 
 
 
TESTIMONIALS
 
 
 
PATIENT REPORTS
View Investigation Report of patients before and after therapy
 
 
 
HEALTH PROBLEM
Consult Dr. Rao Online

 
Go

HOME |

FAQ |

CONTACT US | SITEMAP
Home Disease Index Polycythaemia (Erythrocytosis) and Polycythaemia Vera
                                                                                  Our Philosophy

 


Overview

Causes
Symptoms
Risk Factor

Consult the Doctor Back to Disease Index

Overview

 


As with much of medicine, the terminology can be confusing and it is worth clarifying this at the start. Polycythaemia means 'many cells in the blood' and logically speaking the term should be applied to the condition in which there is an increase in all of the blood cell components, ie red cells, white cells and platelets. In practice, however, doctors use the word polycythaemia to mean an increase in red cell numbers.

Erythrocytosis (the alternative correct term) is often used interchangeably with polycythaemia and effectively means the same thing.

Red cells comprise the majority of blood cells and their main function is the transport of oxygen, so their main content is the oxygen-carrying protein, haemoglobin. Red cells have no nucleus and have a special doughnut-like shape, which allows them to bend and squeeze through the smallest of blood vessels in the tissues (see Figure 1).

The number of red cells that should normally be present varies according to a person's age and sex. Men have higher results than women and newborn babies often have higher values than adults.

If it appears that there are too many red blood cells present then the person is said to have an erythrocytosis or a polycythaemia. This increase in red cells may show in a blood test result as an increase in red cell number, or as a rise in haemoglobin, or in the so-called packed cell volume. This is a laboratory measure of the volume of red cells in the blood expressed as a fraction of the total volume of blood and is often also called the haematocrit.

The opposite situation with too few red cells, or a low haemoglobin, is known as anaemia. Sometimes a person might be anaemic but have a disproportionately high number of red cells (considering the anaemia). In this case then both anaemia and an underlying erythrocytosis are present.

An abnormal blood result would normally require a repeat test on a fresh sample as the result can be affected by factors such as the difficulty in obtaining the blood. If a repeat sample shows an erythrocytosis then the person should be investigated further by a haematologist (specialist in blood disorders).




Causes

 

There are many causes of an erythrocytosis as shown in Table 1. These causes may be subdivided into whether there is a 'true' (or absolute) erythrocytosis due to an increase in red cells, or an 'apparent' erythrocytosis (when the red cells are not increased but are instead more concentrated).

The distinction between an absolute and an apparent erythrocytosis is made based upon the result of an investigation known as the red cell mass and plasma volume test (see below). An absolute erythrocytosis is then further categorised into primary or secondary causes according to whether the abnormality is within (primary) or outside (secondary) the red cell itself.

Rarely an absolute erythrocytosis can be inherited. The only cause of a primary inherited erythrocytosis that has been described so far is a mutation in the receptor that binds to the cytokine, or hormone, that stimulates the synthesis of red cells – the process called erythropoiesis. This cytokine is known as erythropoietin and its site of manufacture is within specialised oxygen-sensitive cells within the kidneys.

The mutation in the erythropoietin receptor removes the portion of the receptor that would normally dampen the positive action of erythropoietin binding to the receptor. Thus the overall result of this mutation is an unchecked increase in red cell production, causing an erythrocytosis.

Inherited causes of a secondary erythrocytosis include a type (variant) of haemoglobin that binds more tightly to oxygen than normal). This higher affinity for oxygen will result in less oxygen being delivered to the tissues of the body. The body compensates for this by increasing the total quantity of haemoglobin (and thus red cells).

Another rare cause of inherited secondary erythrocytosis in some individuals is a higher-than-normal level of erythropoietin. Finally some people inherit a lower-than-normal concentration of a compound called 2,3 diphosphoglycerate [2,3,DPG]. This compound reduces the affinity of haemoglobin for oxygen and the effect of this abnormality is a compensatory erythrocytosis.

Much more commonly erythrocytosis is not inherited but occurs as a result of a disease process in the individual. These acquired erythrocytoses most frequently arise from a stimulus to increase red cell production arising from outside the bone marrow (secondary erythrocytosis). Less often it occurs due to a primary abnormality of the red cells in the bone marrow itself, otherwise known as polycythaemia rubra vera (PV). Secondary acquired erythrocytoses fall into two main groups. First is reduced oxygen supply to the kidney, perhaps from blockage to a kidney artery or because the person's general oxygen state is reduced through lung disease. This causes a reflex increase in the production of erythropoietin and hence an increase in red cell production. In the other group of secondary erythrocytoses there is enhanced erythropoietin production, often caused by a tumour, as listed in Table 1.



Symptoms

 

 

 

Risk Factors

 


  Click here for Therapy


Consult the Doctor Back to Disease Index

Top